£97.49

Nova Science Publishers Inc ADVANCED CANCER: Managing Symptoms & Quality of Life (Health and Human Development)

Price data last checked 55 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£97 today · all-time low £96 (Mar 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 36 days • 36 data points (No recent data available)

Historical
Generating forecast...
£159.62 £89.36 £104.69 £120.02 £135.35 £150.68 £166.01 11 March 2026 19 March 2026 28 March 2026 06 April 2026 15 April 2026

Price Distribution

Price distribution over 36 days • 3 price levels

Days at Price
Current Price
2 days 1 day · current 33 days 0 8 17 25 33 £96 £97 £160 Days at Price

Price Analysis

Most common price: £160 (33 days, 91.7%)

Price range: £96 - £160

Price levels: 3 different prices over 36 days

Description

Bone metastases are a common event for cancer patients. We have developed an innovative and unique clinical research program dedicated to palliative radiation oncology at the Odette Cancer Centre, Sunnybrook Health Sciences Centre and specifically a multidisciplinary clinic for bone metastases. The development of this program introduces an effective strategy to conduct research in palliative radiation oncology. Symptom control is very important for the quality of life for bone and brain metastases patients. This is an evolving active field of research as greater emphasis is being placed into understanding the goals of improving not only a patient's survival, but the ability for therapies to improve the quality of a patient's life. In this book we present the EORTC QLQ-C30 questionnaire, which was used in a multi-center study with patients recruited from Edmonton, Alberta, Canada; Kaohsiung, Taiwan; Kerala, India; Nicosia, Cyprus; Sao Paulo, Brazil; Taipei, Taiwan; Tanta, Egypt; and Toronto, Ontario, Canada, with brain and bone metastases. It was found that the difficulties bone and brain metastases patients experience are different in several ways. Patients with bone metastases have more pain and reduced physical functioning. However, patients with brain metastases have more severe role functioning deficits. With use of the QLQ-C30, it was also found that there is ambiguity regarding the root of patient issues. Future studies that require more comprehensive disease-specific findings should include disease-specific assessment modules such as the QLQ-BM22 and QLQ-BN20. Important domains such as the minimal clinically important difference should also be established in individual subgroups of patients to assist in clinical trial design.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Bone Metastases: A translational and clinical approach: 12 (Cancer Metastasis - Biology and Treatment, 12)
96% match

Bone Metastases: A translational and clinical approach: 12 (Cancer Metastasis - Biology and Treatment, 12)

Springer

£129.99 15 Apr 2026
TxNxM1: The Anatomy and Clinics of Metastatic Cancer
96% match

TxNxM1: The Anatomy and Clinics of Metastatic Cancer

Springer

£155.18 25 Jan 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
96% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Cancer in Context: A Practical Guide To Supportive Care (Oxford Medical Publications)
96% match

Cancer in Context: A Practical Guide To Supportive Care (Oxford Medical Publications)

Oxford University Press

£110.40 25 Jan 2026
Bone Cancer: Primary Bone Cancers and Bone Metastases
96% match

Bone Cancer: Primary Bone Cancers and Bone Metastases

Academic Press

£102.19 25 Feb 2026
Psycho-Oncology: 197 (Recent Results in Cancer Research, 197)
96% match

Psycho-Oncology: 197 (Recent Results in Cancer Research, 197)

Springer

£76.62 27 Feb 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)
96% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Springer

£175.38 08 Apr 2026
Late Sequelae in Oncology (Medical Radiology)
96% match

Late Sequelae in Oncology (Medical Radiology)

Springer

£77.90 08 Mar 2026
Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice
96% match

Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice

Wiley-Blackwell

£124.49 16 Apr 2026
Springer - Signaling Pathways and Molecular Mediators in Metastasis
96% match

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Springer

£114.94 20 Apr 2026
Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America: Volume 38-1 (The Clinics: Internal Medicine, Volume 38-1)
96% match

Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America: Volume 38-1 (The Clinics: Internal Medicine, Volume 38-1)

Elsevier

£71.63 05 Mar 2026
Evidence–Based Oncology (Evidence–Based Medicine)
96% match

Evidence–Based Oncology (Evidence–Based Medicine)

Wiley-Blackwell

£175.00 23 Jan 2026
Cancer Metastasis: from Mechanisms to Therapies (Molecular Medical Science Series)
96% match

Cancer Metastasis: from Mechanisms to Therapies (Molecular Medical Science Series)

Wiley-Blackwell

£100.00 26 Feb 2026
Bone Cancer: Progression and Therapeutic Approaches
96% match

Bone Cancer: Progression and Therapeutic Approaches

Academic Press

£69.84 24 Feb 2026
Study Guide for the Core Curriculum for Oncology Nursing
96% match

Study Guide for the Core Curriculum for Oncology Nursing

Elsevier

£53.91 08 Jan 2026
Acute Care Oncology Nursing
96% match

Acute Care Oncology Nursing

Saunders

£45.49 26 Feb 2026
Cancer Metastasis: Experimental Approaches (Volume 29) (Laboratory Techniques in Biochemistry and Molecular Biology, Volume 29)
96% match

Cancer Metastasis: Experimental Approaches (Volume 29) (Laboratory Techniques in Biochemistry and Molecular Biology, Volume 29)

Elsevier

£160.19 07 Mar 2026
Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)
96% match

Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)

Springer

£245.82 22 Jan 2026
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)
96% match

Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)

Springer

£201.60 13 Jan 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
96% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.36 10 Mar 2026
Oxford Textbook of Oncology
96% match

Oxford Textbook of Oncology

Oxford University Press

£163.06 14 Jan 2026
Management of Bone Metastases: A Multidisciplinary Guide
96% match

Management of Bone Metastases: A Multidisciplinary Guide

Springer

£53.54 06 Mar 2026
Management in Neuro-Oncology (ESO Monographs)
96% match

Management in Neuro-Oncology (ESO Monographs)

Springer

£77.79 01 Mar 2026
Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)
96% match

Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)

Springer

£119.87 27 Feb 2026